Dr. Reddy’s expects first lot of Russia’s COVID-19 vaccine Sputnik V by May-end
The Hindu
Once available, Sputnik V will be the third vaccine to be used in India against coronavirus
Dr. Reddy’s Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccine Sputnik V, on April 27 said it expects the first lot of stock from Russian Direct Investment Fund (RDIF) by May-end. In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the rights for distribution of the first 100 million doses in India. Later, it was enhanced to 125 million.More Related News
Lok Sabha Elections: Hibi Eden walks into book of political records with a margin of 2.50 lakh votes
Hibi Eden wins Ernakulam Lok Sabha seat with record margin, emerging as a political superstar for Congress.